This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

JAMA. 2002;288:36.

	Since this article does not have an abstract, we have provided the first 90 words of the full text and any section headings.

The FDA and the American Society for Clinical Pharmacology and Therapeutics will hold a symposium on July 22-23, 2002, on drug interactions with herbal products. The discussions will include mechanisms by which herbal products selectively modulate cytochrome P-450 and P-glucoprotein–mediated elimination; the clinical importance of drug/grapefruit interactions; and regulatory standards that influence food product safety and claims. The symposium will be held at the Hyatt Regency Hotel in Bethesda, Md. For more information, log onto http://www.fda.gov/cder/workshop.htm.

Lester M. Crawford, Jr, DVM, PhD
Deputy Commissioner
US Food and Drug Administration